Albumin, with its antioxidant and anti-inflammatory properties, is neuroprotective (33–35), while CRP is a commonly used inflammatory marker in clinical practice to reflect the degree of inflammation at the onset of infection and is associated with the severity, infarct size, and prognosis of AIS patients (36). This evidence concerns the gene CRP and androgen insensitivity syndrome.